Farges O - Search Results

1

A randomized trial of OKT3-based versus cyclosporine-based immunoprophylaxis after liver transplantation. Long-term results of a European and Australian multicenter study.

Farges O, Ericzon BG, Bresson-Hadni S, Lynch SV, Höckerstedt K, Houssin D, Galmarini D, Faure JL, Baldauf C, Bismuth H. Farges O, et al. Transplantation. 1994 Oct 27;58(8):891-8. doi: 10.1097/00007890-199410270-00006. Transplantation. 1994. PMID: 7940732 Clinical Trial.

2

Past, present and future in liver transplantation immunosuppression.

Bismuth H, Farges O, Samuel D, Castaing D. Bismuth H, et al. Among authors: farges o. Transplant Proc. 1992 Aug;24(4 Suppl 2):85-7. Transplant Proc. 1992. PMID: 1496696 No abstract available.

3

Anti-donor antibody class switching after liver transplantation.

Farges O, Buffello D, Shi YM, Berth A, Bismuth H. Farges O, et al. Transplantation. 1995 Aug 15;60(3):296-300. doi: 10.1097/00007890-199508000-00016. Transplantation. 1995. PMID: 7645043

4

Long-term results of ABO-incompatible liver transplantation.

Farges O, Nocci Kalil A, Samuel D, Arulnaden JL, Bismuth A, Castaing D, Bismuth H. Farges O, et al. Transplant Proc. 1995 Apr;27(2):1701-2. Transplant Proc. 1995. PMID: 7725460 No abstract available.

5

The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients.

Farges O, Kalil AN, Samuel D, Saliba F, Arulnaden JL, Debat P, Bismuth A, Castaing D, Bismuth H. Farges O, et al. Transplantation. 1995 Apr 27;59(8):1124-33. Transplantation. 1995. PMID: 7732558

6

Low incidence of chronic rejection in patients experiencing histological acute rejection without simultaneous impairment in liver function tests.

Farges O, Nocci Kalil A, Sebagh M, Reynes M, Bismuth H. Farges O, et al. Transplant Proc. 1995 Feb;27(1):1142-3. Transplant Proc. 1995. PMID: 7878827 No abstract available.

7

Optimal immunosuppressive clinical regimen in liver transplantation.

Farges O, Samuel D, Bismuth H. Farges O, et al. Transplant Proc. 1994 Oct;26(5):2676-8. Transplant Proc. 1994. PMID: 7940838 No abstract available.

8

OKT3 prophylaxis in liver transplant patients: a European and Australian multicenter, prospective controlled trial.

Höckerstedt K, Ericzon BG, Bismuth H, Chapuis Y, Farges O, Faure JL, Galmarini D, Houssin D, Lynch SV, Miguet J. Höckerstedt K, et al. Among authors: farges o. Transplant Proc. 1993 Feb;25(1 Pt 1):556-7. Transplant Proc. 1993. PMID: 8438412 Clinical Trial. No abstract available.

9

High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection.

Dubel L, Farges O, Johanet C, Sebagh M, Bismuth H. Dubel L, et al. Among authors: farges o. Transplantation. 1998 Apr 27;65(8):1072-5. doi: 10.1097/00007890-199804270-00011. Transplantation. 1998. PMID: 9583868

10

FK 506 as treatment of late acute rejection in liver transplant patients.

Rucay P, Samuel D, Farges O, Reynes M, Bismuth H. Rucay P, et al. Among authors: farges o. Transplant Proc. 1995 Feb;27(1):1105-6. Transplant Proc. 1995. PMID: 7533354 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters